<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="47045">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02091427</url>
  </required_header>
  <id_info>
    <org_study_id>METC 12-2-074</org_study_id>
    <nct_id>NCT02091427</nct_id>
  </id_info>
  <brief_title>Circadian Variation of Cardiac Troponin</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Maastricht University Medical Center</source>
  <oversight_info>
    <authority>Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acute myocardial infarction (AMI) is defined by an increase and/or decrease in the
      concentration of cardiac troponin, with at least one value above the 99th percentile value
      of the reference population together with evidence of ischemia. An objective tool to
      determine the magnitude of the cardiac troponin change is the use of reference change values
      (RCV). The basis for this tool is that, for a change to be significant, the difference in
      serial results must be greater than the inherent variation in two test results. The inherent
      variation of a laboratory test result is composed of analytical and within-subject
      biological variation. An important requirement to use RCVs is that the concentrations of
      cardiac troponins fluctuate randomly around a homeostatic set point in cardio-healthy
      individuals. Verification of this important condition has never been performed, and
      violation of this condition would preclude the use of RCV's in clinical practice.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Anticipated">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>N/A</study_design>
  <primary_outcome>
    <measure>cardiac troponins</measure>
    <time_frame>measured every hour, total time 25h (08:30 day 1, till 09:30 day 2)</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Healthy Individuals</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Individuals with no evidence of active cardiovascular disease
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Individuals with no evidence of active cardiovascular disease

        Exclusion Criteria:

          -  History of acute myocardial infarction in the last year
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Lieke Klinkenberg, MSc</last_name>
    <phone>+3143-3871399</phone>
    <email>lieke.klinkenberg@mumc.nl</email>
  </overall_contact>
  <location>
    <facility>
      <name>Maastricht University Medical Center</name>
      <address>
        <city>Maastricht</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 25, 2014</lastchanged_date>
  <firstreceived_date>March 18, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
